NCT03233126View on ClinicalTrials.gov

A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

February 17, 2020

Study Completion Date

February 17, 2020

Conditions
X-linked Hypophosphatemic Rickets/Osteomalacia
Interventions
DRUG

KRN23

Subjects will receive subcutaneous injections of KRN23 every 2 weeks from Week 0 through Week 86

Trial Locations (4)

Unknown

Kanagawa Prefectural Hospital Organization Kanagawa Children's Medical Center, Yokohama

Osaka Hospital, Japan Community Healthcare Organization (JCHO), Osaka

National University Corporation Osaka University Hospital, Suita

Okayama Saiseikai General Hospital Outpatient Center, Okayama

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03233126 - A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia | Biotech Hunter | Biotech Hunter